Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study

Clinical Chemistry

Volumn 42, Issue 11, 1996, Pages 1817-1823

  Lahoz, Carlos ^a,b   Osgood, Doreen ^a,b   Wilson, Peter W F ^a,b   Schaefer, Ernst J ^a,b   Ordovas, Jose M ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b Framingham Study   (United States)

Author keywords

genetic epidemiology; genetics; lipids; polymerase chain reaction

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGED; ALLELE; ALZHEIMER DISEASE; ARTICLE; CHROMOSOME 19; DEMENTIA; FEMALE; GENE LOCUS; GENETIC VARIABILITY; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; POLYMERASE CHAIN REACTION; RISK FACTOR;

EID: 0029826254     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/42.11.1817     Document Type: Article

References (38)

1. Mahley RW. Apolipoprotein E: cholesterol transport protein with expanding role in cell biology. Science 1988;240:622-30.
2. Rall SC, Weisgraber KH, Mahley RW. Human apolipoprotein E: the complete amino acid sequence. J Biol Chem 1982;257:4171-8.
3. Schaefer EJ, Lamon-Fava S, Johnson S, Ordovas JM, Schaefer MM, Castelli WP, et al. Effects of gender and menopausal status on the association of apolipoprotein E phenotype with plasma lipoprotein levels: results from the Framingham Offspring Study. Arterioscler Thromb 1994;14:1105-13.
4. Wilson PWF, Myers RH, Larson MG, Ordovas JM, Wolf PA, Schaefer EJ. Apolipoprotein E alleles, dyslipidemia, and coronary heart disease: the Framingham Offspring Study. JAMA 1994; 272:1666-71.
5. Saunders AM, Strittmatter WJ, Schmechel D, George-Hyslop S, Pericak-Vance MA, Joo SH, et al. Association of apolipoprotein E allele ∈4 with late-onset familial and sporadic Alzheimer's disease. Neurology 1993;43:1467-72.
6. Lopez-Miranda J, Ordovas JM, Mata P, Lichtenstein AH, Clevidence B, Judd JT, et al. Effect of apolipoprotein E phenotype on diet-induced lowering of plasma low density lipoprotein cholesterol. J Lipid Res 1994;35:1965-75.
7. Ordovas JM, Lopez-Miranda J, Perez-Jimenez F, Rodriguez C, Park JS, Cole T, et al. Effect of apolipoprotein E and A-IV phenotypes on the low density lipoprotein response to HMG CoA reductase inhibitor therapy. Atherosclerosis 1995;113:157-66.
8. Ordovas JM, Litwack-Klein L, Wilson PWF, Schaefer MM, Schaefer EJ. Apolipoprotein E isoform phenotyping methodology and population frequency with identification of apoE1 and apoE5 isoforms. J Lipid Res 1987;28:371-80.
9. Menzel HJ, Utermann G. Apolipoprotein E phenotyping from serum by western blotting. Electrophoresis 1986;7:492-6.
10. Hixson JE, Vernier DT. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990;31:545-8.
11. Walden CC, Hegele RA. Apolipoprotein E in hyperlipidemia. Ann Intern Med 1994;120:1026-36.
12. Kontula K, Aalto-Setälä K, Kuusi T, Hämäläinen L, Syvänen A-C. Apolipoprotein E polymorphism determined by restriction enzyme analysis of DNA amplified by polymerase chain reaction: convenient alternative to phenotyping by isoelectric focusing. Clin Chem 1990;36:2087-92.
13. Snowden C, Houlston RS, Arif MH, Laker MF, Humphries SE, Alberti KGMM. Disparity between apolipoprotein E phenotypes and genotypes (as determined by polymerase chain reaction and oligonucleotide probes) in patients with non-insulin-dependent diabetes mellitus. Clin Chim Acta 1991;196:49-58.
14. Wenham PR, Sedky A, Spooner RJ. Apolipoprotein E phenotyping: a word of caution. Ann Clin Biochem 1991;28:599-605.
15. Mailly F, Moll P, Kottke BA, Kamboh MI, Humphries SE, Ferrell RE. Estimation of the frequency of isoform-genotype discrepancies at the apolipoprotein E locus in heterozygotes for the isoforms. Genet Epidemiol 1992;9:239-48.
16. Tsukamoto K, Watanabe T, Matsushima T, Kinoshita M, Kato H, Hashimoto Y, et al. Determination by PCR-RFLP of apo E genotype in a Japanese population. J Lab Clin Med 1993;121:598-602.
17. Tsai MY, Suess P, Schwichtenberg K, Eckfeldt JH, Yuan J, Tuchman M, et al. Determination of apolipoprotein E genotypes by single-strand conformational polymorphism. Clin Chem 1993;39: 2121-4.
18. Stavljenic-Rukavina A, Sertic J, Salzer B, Dumic M, Radica A, Fumic K, et al. Apolipoprotein E phenotypes and genotypes as determined by polymerase chain reaction using allele-specific oligonucleotide probes and the amplification refractory mutation system in children with insulin-dependent diabetes mellitus. Clin Chim Acta 1993;216:191-8.
19. James RW, Ruiz J, Blanché H, Pometta D, Passa P, Froguel P. Phenotyping is an accurate means of analysing the principal apolipoprotein E isoforms. Clin Chim Acta 1994;225:77-82.
20. Hansen PS, Gerdes LU, Klausen IC, Gregersen N, Faergeman O. Genotyping compared with protein phenotyping of the common apolipoprotein E polymorphism. Clin Chim Acta 1994;224:131-7.
21. Boerwinkle E, Visvikis S, Welsh D, Steinmetz J, Hanash SM, Sing CF. The use of measured genotype information in the analysis of quantitative phenotypes in man. II. The role of the apolipoprotein E polymorphism in determining levels, variability and covariability of cholesterol, betalipoprotein and triglycerides in a sample of unrelated individuals. Am J Med Genet 1987;27:567-82.
22. Kannel WB, Feinleib M, McNamara PM, Garrison RJ, Castelli WP. An investigation of coronary heart disease in families: the Framingham Offspring Study. Am J Epidemiol 1979;110:281-90.
23. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1989;16:1215.
24. 2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 1982;28:1379-88.
25. Morrison PJ, Graham CA, Nevin NC. DNA storage and duplicate sampling: lesson learnt from testing for Huntington's disease. J Med Genet 1993;30:1042.
26. Black SC, Hewett S, Kotubi Y, Brunt RV, Reckless JPD. Isoform patterns of apolipoprotein E in diabetes mellitus. Diabet Med 1990;7:532-9.
27. Aozaki R, Kawaguchi R, Ogasu U, Hikiji K, Kubo N, Sakuraboyashi I. Rapid identification of the common apoE isoforms genotype using polymerase chain reaction-single strand conformation polymorphism (PCR-SSCP). Mol Cell Probes 1994;8:51-4.
28. Maekawa B, Cole TG, Seip RL, Bylund D. Apolipoprotein E genotyping methods for the clinical laboratory. J Clin Lab Anal 1995;9:63-9.
29. Davignon J, Gregg RE, Sing CF. Apolipoprotein E polymorphism and atherosclerosis. Arteriosclerosis 1988;8:1-21.
30. Sing CF, Davignon J. Role of the apolipoprotein E polymorphism in determining normal plasma lipid and lipoprotein variation. Am J Hum Genet 1985;37:268-85.
31. Eto M, Watanabe K, Ishii K. Reciprocal effects of apolipoprotein E alleles (e2 and e4) on plasma lipid levels in normolipidemic subjects. Clin Genet 1986;29:477-84.
32. Bolla MK, Haddad L, Humphries SE, Winder AF, Day IN. High-throughput method for determination of apolipoprotein E genotypes with use of restriction digestion analysis by microplate array diagonal gel electrophoresis. Clin Chem 1995;41:1599-604.
33. Golaz O, Sanchez JC, James RW, Hochstrasser DF. Phenotyping of apolipoprotein E using immobilized pH gradient gels for one-dimensional and two-dimensional separations. Electrophoresis 1995;16:1184-6.
34. Corbo RM, Scacchi R, Mureddu L, Mulas G, Alfano G. Apolipoprotein E polymorphism in Italy investigated in native plasma by a simple polyacrilamide gel isoelectric focusing technique. Comparison with frequency data of other European populations. Ann Hum Genet 1995;59:197-209.
35. Kolhmeier M, Drossel HJ, Sinha P, Kottgen E. Rapid and simple method for the identification of apolipoprotein E isomorphic phenotypes from whole serum. Electrophoresis 1992;13:258-61.
36. Richard P, Thomas G, de Zulueta MP, De gennes JL, Thomas M, Cassaigne A, et al. Common and rare genotypes of human apolipoprotein E determined by specific restriction profiles of polymerase chain reaction-amplified DNA. Clin Chem 1994;40: 24-9.
37. Zannis VI, Kardassis D, Zanni EE. Genetic mutations affecting human lipoproteins, their receptors, and their enzymes. In: Harris H, Hirschhorn K, eds. Advances in human genetics, Vol. 21. New York: Plenum Press, 1993:145-316.
38. Pocovi M, Cenarro A, Civeira F, Myers RH, Casao E, Esteban M, Ordovas JM. Incomplete dominance of type III hyperlipoproteinemia is associated with the rare apolipoprotein E2 (Arg136→Ser) variant in multigenerational pedigree studies. Atherosclerosis 1996;122:33-46.